Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Mecoli

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Emergency Radiology|August 2, 2022
Rapidly progressive interstitial lung disease in patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis: serial changes on HRCTMinsoo Kim, Samuel Harvey, Sonye K Danoff, et al.
The Lancet. Rheumatology|May 3, 2022
Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosisRachel Wallwork, Caoilfhionn M Connolly, Matthew Shneyderman, et al.
Clinical and Experimental Rheumatology|February 25, 2026
Recurrent and new primary cancer risk in adult patients with idiopathic inflammatory myositis and a history of malignancyXingyao Wang, Jemima Albayda, Julie J Paik, et al.
ACR Open Rheumatology|March 1, 2022
Presence and Implications of Anti-Angiotensin Converting Enzyme-2 Immunoglobulin M Antibodies in Anti-Melanoma-Differentiation-Associated 5 DermatomyositisChristopher A Mecoli, Akira Yoshida, Julie J Paik, et al.
Seminars in Arthritis and Rheumatism|March 5, 2026
Clinical characteristics and risk factors associated with objective flares in patients with dermatomyositisDidem Saygin, Xing Yao Wang, Kathryn C Fitzgerald, et al.
Rheumatology (Oxford, England)|June 27, 2021
Prevalence of avascular necrosis in idiopathic inflammatory myopathies: a single-centre experienceKhalil I Bourji, Christopher A Mecoli, Julie J Paik, et al.
ACR Open Rheumatology|October 6, 2024
The Relationship Between Anti-Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti-Sp4 Autoantibodies, and Cancer in Anti-Transcription Intermediary Factor 1γ-Positive DermatomyositisChristopher A Mecoli, David Fiorentino, Jemima Albayda, et al.
Clinical Rheumatology|April 9, 2017
"Hiker's feet": a novel cutaneous finding in the inflammatory myopathiesJacob T Cox, David M Gullotti, Christopher A Mecoli, et al.
Rheumatology (Oxford, England)|August 30, 2024
Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosisJamie Perin, Michael Hughes, Christopher A Mecoli, et al.
Clinical Rheumatology|December 21, 2019
Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1)Christopher A Mecoli, Jamie Perin, Jennifer E Van Eyk, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Emergency Radiology|August 2, 2022
Rapidly progressive interstitial lung disease in patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis: serial changes on HRCTMinsoo Kim, Samuel Harvey, Sonye K Danoff, et al.
The Lancet. Rheumatology|May 3, 2022
Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosisRachel Wallwork, Caoilfhionn M Connolly, Matthew Shneyderman, et al.
Clinical and Experimental Rheumatology|February 25, 2026
Recurrent and new primary cancer risk in adult patients with idiopathic inflammatory myositis and a history of malignancyXingyao Wang, Jemima Albayda, Julie J Paik, et al.
ACR Open Rheumatology|March 1, 2022
Presence and Implications of Anti-Angiotensin Converting Enzyme-2 Immunoglobulin M Antibodies in Anti-Melanoma-Differentiation-Associated 5 DermatomyositisChristopher A Mecoli, Akira Yoshida, Julie J Paik, et al.
Seminars in Arthritis and Rheumatism|March 5, 2026
Clinical characteristics and risk factors associated with objective flares in patients with dermatomyositisDidem Saygin, Xing Yao Wang, Kathryn C Fitzgerald, et al.
Rheumatology (Oxford, England)|June 27, 2021
Prevalence of avascular necrosis in idiopathic inflammatory myopathies: a single-centre experienceKhalil I Bourji, Christopher A Mecoli, Julie J Paik, et al.
ACR Open Rheumatology|October 6, 2024
The Relationship Between Anti-Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti-Sp4 Autoantibodies, and Cancer in Anti-Transcription Intermediary Factor 1γ-Positive DermatomyositisChristopher A Mecoli, David Fiorentino, Jemima Albayda, et al.
Clinical Rheumatology|April 9, 2017
"Hiker's feet": a novel cutaneous finding in the inflammatory myopathiesJacob T Cox, David M Gullotti, Christopher A Mecoli, et al.
Rheumatology (Oxford, England)|August 30, 2024
Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosisJamie Perin, Michael Hughes, Christopher A Mecoli, et al.
Clinical Rheumatology|December 21, 2019
Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1)Christopher A Mecoli, Jamie Perin, Jennifer E Van Eyk, et al.
Pageof 8